Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-6 of 6 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2016A multivariable model to guide the decision for pessary placement to prevent preterm birth in women with a multiple pregnancy: a secondary analysis of the ProTWIN trialTajik, P.; Monfrance, M.; van 't Hooft, J.; Liem, S.; Schuit, E.; Bloemenkamp, K.; Duvekot, J.; Nij Bijvank, B.; Franssen, M.; Oudijk, M.; Scheepers, H.; Sikkema, J.; Woiski, M.; Mol, B.; Bekedam, D.; Bossuyt, P.; Zafarmand, M.
2013Cost-effectiveness of induction of labour at term with a Foley catheter compared to vaginal prostaglandin E₂ gel (PROBAAT trial)van Baaren, G.; Jozwiak, M.; Opmeer, B.; Oude Rengerink, K.; Benthem, M.; Dijksterhuis, M.; van Huizen, M.; van der Salm, P.; Schuitemaker, N.; Papatsonis, D.; Perquin, D.; Porath, M.; van der Post, J.; Rijnders, R.; Scheepers, H.; Spaanderman, M.; van Pampus, M.; de Leeuw, J.; Mol, B.; Bloemenkamp, K.
2013Foley catheter or prostaglandin E2 inserts for induction of labour at term: an open-label randomized controlled trial (PROBAAT-P trial) and systematic review of literatureJozwiak, M.; Oude Rengerink, K.; Ten Eikelder, M.; van Pampus, M.; Dijksterhuis, M.; de Graaf, I.; van der Post, J.; van der Salm, P.; Scheepers, H.; Schuitemaker, N.; de Leeuw, J.; Mol, B.; Bloemenkamp, K.
2016Fetal fibronectin status and cervical length in women with threatened preterm labor and the effectiveness of maintenance tocolysisRoos, C.; Vis, J.; Scheepers, H.; Bloemenkamp, K.; Duvekot, H.; Van Eyck, J.; De Groot, C.; Kok, J.; Opmeer, B.; Oudijk, M.; Papatsonis, D.; Porath, M.; Sollie, K.; Spaanderman, M.; Lotgering, F.; Van Der Post, J.; Mol, B.
2015Risk stratification with cervical length and fetal fibronectin in women with threatened preterm labor before 34 weeks and not delivering within 7 daysHermans, F.; Bruijn, M.; Vis, J.; Wilms, F.; Oudijk, M.; Porath, M.; Scheepers, H.; Bloemenkamp, K.; Bax, C.; Cornette, J.; Nij Bijvanck, B.; Franssen, M.; Vandenbussche, F.; Kok, M.; Grobman, W.; Van Der Post, J.; Bossuyt, P.; Opmeer, B.; Mol, B.; Schuit, E.; et al.
2015ALIFE2 study: low-molecular-weight heparin for women with recurrent miscarriage and inherited thrombophilia - study protocol for a randomized controlled trialde Jong, P.; Quenby, S.; Bloemenkamp, K.; Braams-Lisman, B.; de Bruin, J.; Coomarasamy, A.; David, M.; DeSancho, M.; van der Heijden, O.; Hoek, A.; Hutten, B.; Jochmans, K.; Koks, C.; Kuchenbecker, W.; Mol, B.; Torrance, H.; Scheepers, H.; Stephenson, M.; Verhoeve, H.; Visser, J.; et al.